Andrew Pavia, M.D.

Financial relationships

  • Attribution: 
    Self
    Ineligible company: 
    GlaxoSmithKline
    Topic: 
    Influenza test
  • Attribution: 
    Self
    Ineligible company: 
    Pfizer
    Topic: 
    Early antiviral candidates
Return to 2022 Infectious Disease Board Review Course